AAAAAA

   
Results: 1-17 |
Results: 17
Multidrug-resistant bacteria infection control: Study of compliance with isolation precautions in a Paris University hospital
Authors: Vidal-Trecan, GM Delamare, N Tcherny-Lessenot, S Lamory, J Baudin, F de Prittwitz, M Salmon-Ceron, D
Citation: Gm. Vidal-trecan et al., Multidrug-resistant bacteria infection control: Study of compliance with isolation precautions in a Paris University hospital, INFECT CONT, 22(2), 2001, pp. 109-111
Hospital epidemiology of patients co-infected by HIV and HCV
Authors: Thelot, B Pialoux, G Delhommeau, A Piroth, L Salmon-Ceron, D
Citation: B. Thelot et al., Hospital epidemiology of patients co-infected by HIV and HCV, MED MAL INF, 31(10), 2001, pp. 601-604
Hospital epidemiology of patients co-infected by HIV and HCV
Authors: Thelot, B Pialoux, G Delhommeau, A Piroth, L Salmon-Ceron, D
Citation: B. Thelot et al., Hospital epidemiology of patients co-infected by HIV and HCV, MED MAL INF, 31(10), 2001, pp. 605-608
Possible interaction between gliclazide, fluconazole and sulfamethoxazole resulting in severe hypoglycaemia
Authors: Abad, S Moachon, L Blanche, P Bavoux, F Sicard, D Salmon-Ceron, D
Citation: S. Abad et al., Possible interaction between gliclazide, fluconazole and sulfamethoxazole resulting in severe hypoglycaemia, BR J CL PH, 52(4), 2001, pp. 456-457
Mitochondrial toxic effects and ribavirin
Authors: Salmon-Ceron, D Chauvelot-Moachon, L Abad, S Silbermann, B Sogni, P
Citation: D. Salmon-ceron et al., Mitochondrial toxic effects and ribavirin, LANCET, 357(9270), 2001, pp. 1803-1804
Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients
Authors: Burrer, R Salmon-Ceron, D Richert, S Pancino, G Spiridon, G Haessig, S Roques, V Barre-Sinoussi, F Aubertin, AM Moog, C
Citation: R. Burrer et al., Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients, J VIROLOGY, 75(11), 2001, pp. 5421-5424
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
Authors: Besson, C Goubar, A Gabarre, J Rozenbaum, W Pialoux, G Chatelet, FP Katlama, C Charlotte, F Dupont, B Brousse, N Huerre, M Mikol, J Camparo, P Mokhtari, K Tulliez, M Salmon-Ceron, D Boue, F Costagliola, D Raphael, M
Citation: C. Besson et al., Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy, BLOOD, 98(8), 2001, pp. 2339-2344
IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects
Authors: Raux, M Finkielsztejn, L Salmon-Ceron, D Bouchez, H Excler, JL Dulioust, E Grouin, JM Sicard, D Blondeau, C
Citation: M. Raux et al., IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects, AIDS RES H, 16(6), 2000, pp. 583-594
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy
Authors: Salmon-Ceron, D Mazeron, MC Chaput, S Boukli, N Senechal, R Houhou, N Katlama, C Matheron, S Fillet, AM Gozlan, J Leport, C Jeantils, V Freymuth, F Costagliola, D
Citation: D. Salmon-ceron et al., Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy, AIDS, 14(8), 2000, pp. 1041-1049
Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection
Authors: de la Blanchardiere, A Rozenberg, F Caumes, E Picard, O Lionnet, F Livartowski, J Coste, J Sicard, D Lebon, P Salmon-Ceron, D
Citation: A. De La Blanchardiere et al., Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection, SC J IN DIS, 32(3), 2000, pp. 263-269
HIV protease inhibitors
Authors: Silbermann, B Yousry, C Salmon-Ceron, D
Citation: B. Silbermann et al., HIV protease inhibitors, ANN MED IN, 151(4), 2000, pp. 268-277
Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients
Authors: Salmon-Ceron, D Deleuze, J Coste, J Guerin, C Ginsburg, C Blanche, P Finkielsztejn, L Pecqueux, L Chaput, S Gorin, I Sicard, D
Citation: D. Salmon-ceron et al., Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients, ANN MED IN, 151(4), 2000, pp. 297-302
Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patientswith persistent CMV viremia
Authors: Salmon-Ceron, D Fillet, AM Aboulker, JP Gerard, L Houhou, N Carriere, I Ostinelli, J Vilde, JL Brun-Vezinet, F Leport, C
Citation: D. Salmon-ceron et al., Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patientswith persistent CMV viremia, CLIN INF D, 28(4), 1999, pp. 901-905
Safety and immunogenicity of a live recombinant canarypox virus expressingHIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection
Authors: Salmon-Ceron, D Excler, JL Finkielsztein, L Autran, B Gluckman, JC Sicard, D Matthews, TJ Meignier, B Valentin, C El Habib, R Blondeau, C Raux, M Moog, C Tartaglia, J Chong, P Klein, M Milcamps, B Heshmati, F Plotkin, S
Citation: D. Salmon-ceron et al., Safety and immunogenicity of a live recombinant canarypox virus expressingHIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection, AIDS RES H, 15(7), 1999, pp. 633-645
Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects
Authors: Raux, M Finkielsztejn, L Salmon-Ceron, D Bouchez, H Excler, JL Dulioust, E Grouin, JM Sicard, D Blondeau, C
Citation: M. Raux et al., Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects, AIDS RES H, 15(15), 1999, pp. 1365-1376
The POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes), multicentric Castleman's disease, chromophobic renal cell carcinoma and herpesvirus-8 infection
Authors: Belec, L Salmon-Ceron, D Blanche, P Dreyfus, F Zuber, M Sicard, D
Citation: L. Belec et al., The POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes), multicentric Castleman's disease, chromophobic renal cell carcinoma and herpesvirus-8 infection, ANN PATHOL, 19(4), 1999, pp. 373-374
Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients
Authors: Raux, M Finkielsztejn, L Salmon-Ceron, D Bouchez, H Excler, JL Dulioust, E Grouin, JM Sicard, D Blondeau, C
Citation: M. Raux et al., Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients, J IMMUNOL M, 222(1-2), 1999, pp. 111-124
Risultati: 1-17 |